Ficlatuzumab Biosimilar (HGF / SF Reference Antibody)
Ficlatuzumab is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF) . Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion.
Product Specifications
Target
Ficlatuzumab Biosimilar (Anti-HGF / SF Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cancer Biology
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog